🔎 Trials Near Me

Akèy › Kansè lestomak › Distrik Columbia › Washington

Etid klinik pou Kansè lestomak nan Washington, DC

16 etid pou Kansè lestomak ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Vanguard Study: Testing a New Way to Screen for Cancer

Ap rekriteVolontè an sante akeyi
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Laj 45 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06995898

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 2 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT01915225

Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 6 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04557969

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 2 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT01950572

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Ap rekriteFaz 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT06885697

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Ap rekriteFaz 2/3
  • Maryland Oncology Hematology, P.A., Silver Spring · 7 mi lwen
  • Maryland Oncology Hematology, P.A., Bethesda · 7 mi lwen
  • Maryland Oncology Hematology, P.A., Largo · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07392892

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Ap rekriteFaz 2
  • Research Site, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07069712

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Ap rekriteFaz 1
  • Georgetown University Medical Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07227168

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Ap rekriteFaz 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 72 · Tout sèks · Mizajou Aug 24, 2026 · NCT03190941

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • National Institutes of Health, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Ap rekriteFaz 3
  • Maryland Oncology Hematology, P.A., Silver Spring · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06731478

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou May 19, 2026 · NCT06503146

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Cancer Support Community Research & Training Institute, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT02333604

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Silver Spring · 7 mi lwen
  • Massive Bio SYNERGY-AI site, Bethesda · 7 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè lestomak nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.